Evidence map›Paper›PMID 40213067›Full record

ArticleSmall science2025

Nanoengineered Shape-Memory Hemostat.

Sarah E Hargett, Giriraj K Lokhande, Joseph Duran, Zanir Hirani, Lindy K Jang, Samantha Foster, Kaivalya A Deo, Sasha George, Mahjabeen Javed, Taylor H Ware and 2 more

Erratum issuedAbstract read
In one paragraph

Article in Small science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Sarah E HargettDepartment of Biomedical Engineering College of Engineering Texas A&M University College Station TX 77843 USA.ORCID https://orcid.org/0000-0002-5389-6344
Giriraj K LokhandeDepartment of Biomedical Engineering College of Engineering Texas A&M University College Station TX 77843 USA.
Joseph DuranDepartment of Biomedical Engineering College of Engineering Texas A&M University College Station TX 77843 USA.
Zanir HiraniDepartment of Biomedical Engineering College of Engineering Texas A&M University College Station TX 77843 USA.
Lindy K JangDepartment of Biomedical Engineering College of Engineering Texas A&M University College Station TX 77843 USA.
Samantha FosterInterdisciplinary Program in Genetics Texas A&M University College Station TX 77843 USA.
Kaivalya A DeoDepartment of Biomedical Engineering College of Engineering Texas A&M University College Station TX 77843 USA.
Sasha GeorgeDepartment of Material Science and Engineering College of Engineering Texas A&M University College Station TX 77843 USA.
Mahjabeen JavedDepartment of Biomedical Engineering College of Engineering Texas A&M University College Station TX 77843 USA.
Taylor H WareDepartment of Biomedical Engineering College of Engineering Texas A&M University College Station TX 77843 USA.
Duncan J MaitlandDepartment of Biomedical Engineering College of Engineering Texas A&M University College Station TX 77843 USA.ORCID https://orcid.org/0000-0001-7001-3761
Akhilesh K GaharwarDepartment of Biomedical Engineering College of Engineering Texas A&M University College Station TX 77843 USA.ORCID https://orcid.org/0000-0002-0284-0201

Funding

Mineralomics: Designing mineral based therapeutics to control and direct cell functionDP2EB026265 · NIBIB · TEXAS ENGINEERING EXPERIMENT STATION · PI GAHARWAR, AKHILESH K. · 2017 to 2021
$2.4M
NIBIB NIH HHS DP2 EB026265
6 · The paper itself

Abstract

Uncontrolled hemorrhage is the predominant cause of preventable combat deaths. Various biomaterials serve as hemostatic agents due to their procoagulant or absorptive activity. However, these biomaterials often lack expansion capabilities, which severely limits use in noncompressible wounds. This study combines a hemostatic nanocomposite with a shape-memory polymer foam to design a composite material with both hemostatic and physical expansion properties. This composite is fabricated in two formulations: a foam externally coated in a highly concentrated nanocomposite ("coated composite") and a foam containing a diluted nanocomposite infused throughout its pores ("infused composite"). Both formulations retain the shape-memory foam's expansion property. Further, the coated composite shows improved fluid uptake (>2-fold) versus infused composites or foam. The nanocomposite component dissociates from the foam under degradative conditions, with the foam remaining stable for 30 days. Hemostatic studies illustrate that the coated composite reduces the clotting time by ≈20%. Alternatively, the infused composite improves clotting over a larger distance (up to ≈2× distance from the composite). These results signify a modular hemostatic ability: the coated composite reduces clotting and improves fluid uptake, while the infused composite achieves diffuse clotting and maintains mechanical properties. Thus, these materials pose a strong potential for use in noncompressible wounds.

Indexed as

expandable biomaterialshemostatsnanocompositesporous materialswound healing

Identifiers

PMID40213067
PMCPMC11934902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.